453 related articles for article (PubMed ID: 18359262)
41. Anxiety, depression and swallowing disorders in patients with Parkinson's disease.
Manor Y; Balas M; Giladi N; Mootanah R; Cohen JT
Parkinsonism Relat Disord; 2009 Jul; 15(6):453-6. PubMed ID: 19071054
[TBL] [Abstract][Full Text] [Related]
42. Sweating dysfunction in Parkinson's disease.
Swinn L; Schrag A; Viswanathan R; Bloem BR; Lees A; Quinn N
Mov Disord; 2003 Dec; 18(12):1459-63. PubMed ID: 14673882
[TBL] [Abstract][Full Text] [Related]
43. Mortality in Parkinson's disease and its association with dementia and depression.
Hughes TA; Ross HF; Mindham RH; Spokes EG
Acta Neurol Scand; 2004 Aug; 110(2):118-23. PubMed ID: 15242420
[TBL] [Abstract][Full Text] [Related]
44. International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease.
Martinez-Martin P; Rodriguez-Blazquez C; Abe K; Bhattacharyya KB; Bloem BR; Carod-Artal FJ; Prakash R; Esselink RA; Falup-Pecurariu C; Gallardo M; Mir P; Naidu Y; Nicoletti A; Sethi K; Tsuboi Y; van Hilten JJ; Visser M; Zappia M; Chaudhuri KR
Neurology; 2009 Nov; 73(19):1584-91. PubMed ID: 19901251
[TBL] [Abstract][Full Text] [Related]
45. Inappropriate crying and laughing in Parkinson disease and movement disorders.
Siddiqui MS; Fernandez HH; Garvan CW; Kirsch-Darrow L; Bowers D; Rodriguez RL; Jacobson CE; Rosado C; Vaidyanathan S; Foote KD; Okun MS
World J Biol Psychiatry; 2009; 10(3):234-40. PubMed ID: 18609421
[TBL] [Abstract][Full Text] [Related]
46. [Psychometric attributes of the Scales for Outcomes in Parkinson's Disease-Psychosocial (SCOPA-PS): validation in Spain and review].
Martínez-Martín P; Carroza-García E; Frades-Payo B; Rodríguez-Blázquez C; Forjaz MJ; de Pedro-Cuesta J;
Rev Neurol; 2009 Jul 1-15; 49(1):1-7. PubMed ID: 19557692
[TBL] [Abstract][Full Text] [Related]
47. Response to 4-month treatment with reboxetine in Parkinson's disease patients with a major depressive episode.
Pintor L; Baillès E; Valldeoriola F; Tolosa E; Martí MJ; de Pablo J
Gen Hosp Psychiatry; 2006; 28(1):59-64. PubMed ID: 16377367
[TBL] [Abstract][Full Text] [Related]
48. A community-based study of sleep disorders in patients with Parkinson's disease.
Tandberg E; Larsen JP; Karlsen K
Mov Disord; 1998 Nov; 13(6):895-9. PubMed ID: 9827612
[TBL] [Abstract][Full Text] [Related]
49. [Immune factors or depression? Fatigue correlates in Parkinson's disease].
Katsarou Z; Bostantjopoulou S; Hatzizisi O; Giza E; Soler-Cardona A; Kyriazis G
Rev Neurol; 2007 Dec 16-31; 45(12):725-8. PubMed ID: 18075986
[TBL] [Abstract][Full Text] [Related]
50. Health-related quality of life and sleep disorders in Parkinson's disease.
Scaravilli T; Gasparoli E; Rinaldi F; Polesello G; Bracco F
Neurol Sci; 2003 Oct; 24(3):209-10. PubMed ID: 14598091
[TBL] [Abstract][Full Text] [Related]
51. The relationship of pain and health-related quality of life in Korean patients with Parkinson's disease.
Roh JH; Kim BJ; Jang JH; Seo WK; Lee SH; Kim JH; Oh K; Park KW; Lee DH; Koh SB
Acta Neurol Scand; 2009 Jun; 119(6):397-403. PubMed ID: 18976321
[TBL] [Abstract][Full Text] [Related]
52. The relation of testosterone levels with fatigue and apathy in Parkinson's disease.
Kenangil G; Orken DN; Ur E; Forta H; Celik M
Clin Neurol Neurosurg; 2009 Jun; 111(5):412-4. PubMed ID: 19131155
[TBL] [Abstract][Full Text] [Related]
53. Parkinson's Disease Sleep Scale 2: application in an Italian population.
Arnaldi D; Cordano C; De Carli F; Accardo J; Ferrara M; Picco A; Tamburini T; Brugnolo A; Abbruzzese G; Nobili F
Neurol Sci; 2016 Feb; 37(2):283-8. PubMed ID: 26520846
[TBL] [Abstract][Full Text] [Related]
54. Psychometric attributes of the Hospital Anxiety and Depression Scale in Parkinson's disease.
Rodriguez-Blazquez C; Frades-Payo B; Forjaz MJ; de Pedro-Cuesta J; Martinez-Martin P;
Mov Disord; 2009 Mar; 24(4):519-25. PubMed ID: 19177496
[TBL] [Abstract][Full Text] [Related]
55. Melatonin for sleep disturbances in Parkinson's disease.
Dowling GA; Mastick J; Colling E; Carter JH; Singer CM; Aminoff MJ
Sleep Med; 2005 Sep; 6(5):459-66. PubMed ID: 16084125
[TBL] [Abstract][Full Text] [Related]
56. Anxiety and depression: main determinants of health-related quality of life in Brazilian patients with Parkinson's disease.
Carod-Artal FJ; Ziomkowski S; Mourão Mesquita H; Martínez-Martin P
Parkinsonism Relat Disord; 2008; 14(2):102-8. PubMed ID: 17719828
[TBL] [Abstract][Full Text] [Related]
57. Social and clinical determinants of quality of life in Parkinson's disease in a Russian cohort study.
Winter Y; von Campenhausen S; Popov G; Reese JP; Balzer-Geldsetzer M; Kukshina A; Zhukova TV; Bertschi N; Bötzel K; Gusev E; Oertel WH; Dodel R; Guekht A
Parkinsonism Relat Disord; 2010 May; 16(4):243-8. PubMed ID: 20022549
[TBL] [Abstract][Full Text] [Related]
58. Depression in patients with Parkinson's disease: impact on functioning.
Stella F; Banzato CE; Barasnevicius Quagliato EM; Viana MA
J Neurol Sci; 2008 Sep; 272(1-2):158-63. PubMed ID: 18589453
[TBL] [Abstract][Full Text] [Related]
59. The effect of pramipexole on mood and motivational symptoms in Parkinson's disease: a meta-analysis of placebo-controlled studies.
Leentjens AF; Koester J; Fruh B; Shephard DT; Barone P; Houben JJ
Clin Ther; 2009 Jan; 31(1):89-98. PubMed ID: 19243709
[TBL] [Abstract][Full Text] [Related]
60. Sleep patterns in Parkinson's disease patients with visual hallucinations.
Barnes J; Connelly V; Wiggs L; Boubert L; Maravic K
Int J Neurosci; 2010 Aug; 120(8):564-9. PubMed ID: 20615061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
